New hybrid molecule uses Trojan horse approach to treat obesity
Hybrid Molecule Shows Promise in Obesity and Type 2 Diabetes Treatment Researchers at Helmholtz Munich have unveiled a novel approach to tackling obesity and type 2 diabetes, utilizing a “Trojan horse” molecule that combines the benefits of existing incretin therapies with a targeted metabolic modulator. The preclinical study, published in Nature, demonstrates significant weight loss … Read more